M1-polarized macrophage-derived cellular nanovesicle-coated lipid nanoparticles for enhanced cancer treatment through hybridization of gene therapy and cancer immunotherapyACTA PHARMACEUTICA SINICA BIF14.62024-07-010OAAI
Nanoengineered Polymeric RNA Nanoparticles for Controlled Biodistribution and Efficient Targeted Cancer TherapyACS NANOIF162024-03-066PRE
Surface-Functionalized Polymeric siRNA Nanoparticles for Tunable Targeting and Intracellular Delivery to Hematologic Cancer CellsBIOMACROMOLECULESIF5.42022-04-0113PRE
Anisotropically Functionalized Aptamer-DNA Nanostructures for Enhanced Cell Proliferation and Target-Specific Adhesion in 3D Cell CulturesBIOMACROMOLECULESIF5.42021-06-1110PREAI
DNA-Assisted Smart Nanocarriers: Progress, Challenges, and OpportunitiesACS NANOIF162021-01-2544PREAI
Multifunctional DNA Nanogels for Aptamer-Based Targeted Delivery and Stimuli-Triggered Release of Cancer TherapeuticsMACROMOLECULAR RAPID COMMUNICATIONSIF4.32020-11-2325PREAI
Cationic cellulose nanocrystals complexed with polymeric siRNA for efficient anticancer drug deliveryCARBOHYDRATE POLYMERSIF12.52020-11-0131PREAI
Optimization of phytic acid-crosslinked chitosan microspheres for oral insulin delivery using response surface methodologyINTERNATIONAL JOURNAL OF PHARMACEUTICSIF5.22020-10-0125PREAI
Cancer Cells Resist Mechanical Destruction in Circulation via RhoA/Actomyosin-Dependent Mechano-AdaptationCELL REPORTSIF6.92020-03-0174OAAI
Dual-targeting RNA nanoparticles for efficient delivery of polymeric siRNA to cancer cellsCHEMICAL COMMUNICATIONSIF4.22020-01-0122PREAI
A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancerSCIENTIFIC REPORTSIF3.92019-01-2423OAAI
Size-controlled synthesis of polymerized DNA nanoparticles for targeted anticancer drug deliveryCHEMICAL COMMUNICATIONSIF4.22019-01-0123PREAI
Nanoparticle-Patterned Multicompartmental Chitosan Capsules for Oral Delivery of OligonucleotidesACS BIOMATERIALS SCIENCE & ENGINEERINGIF5.52018-11-1420PREAI
5-Nitro-5′-hydroxy-indirubin-3′-oxime (AGM130), an indirubin-3′-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivoEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCESIF4.72015-11-0129PREAI
Mechanism of Photoinduced Bending and Twisting in Crystalline Microneedles and Microribbons Composed of 9-MethylanthraceneJOURNAL OF THE AMERICAN CHEMICAL SOCIETYIF15.62014-04-29192PREAI
Overexpression of Transcription Factor Sp2 Inhibits Epidermal Differentiation and Increases Susceptibility to Wound- and Carcinogen-Induced TumorigenesisCANCER RESEARCHIF16.62010-10-3119OAAI
Reflective dual-mode liquid crystal display switchable between dynamic and memory modesAPPLIED PHYSICS LETTERSIF3.62010-10-013PREAI